C4 Therapeutics, Inc. (CCCC)
4.11
+0.11
(+2.75%)
USD |
NASDAQ |
Aug 24, 16:00
4.07
-0.04
(-0.97%)
After-Hours: 20:00
C4 Therapeutics Max Drawdown (5Y) : 97.82% for July 31, 2026
Max Drawdown (5Y) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Max Drawdown (5Y) Data
| Date | Value |
|---|---|
| July 31, 2026 | 97.82% |
| June 30, 2026 | 97.82% |
| May 31, 2026 | 97.82% |
| April 30, 2026 | 97.82% |
| March 31, 2026 | 97.82% |
| February 28, 2026 | 97.82% |
| January 31, 2026 | 97.82% |
| December 31, 2025 | 97.82% |
| November 30, 2025 | 97.82% |
| October 31, 2025 | 97.82% |
| September 30, 2025 | 97.82% |
| August 31, 2025 | 97.82% |
| July 31, 2025 | 97.82% |
| June 30, 2025 | 97.82% |
| May 31, 2025 | 97.82% |
| April 30, 2025 | 97.82% |
| March 31, 2025 | 97.66% |
| February 28, 2025 | 97.66% |
| January 31, 2025 | 97.66% |
| December 31, 2024 | 97.66% |
| November 30, 2024 | 97.66% |
| October 31, 2024 | 97.66% |
| September 30, 2024 | 97.66% |
| August 31, 2024 | 97.66% |
| July 31, 2024 | 97.66% |
| Date | Value |
|---|---|
| June 30, 2024 | 97.66% |
| May 31, 2024 | 97.66% |
| April 30, 2024 | 97.66% |
| March 31, 2024 | 97.66% |
| February 29, 2024 | 97.66% |
| January 31, 2024 | 97.66% |
| December 31, 2023 | 97.66% |
| November 30, 2023 | 97.39% |
| October 31, 2023 | 97.27% |
| September 30, 2023 | 96.42% |
| August 31, 2023 | 94.55% |
| July 31, 2023 | 94.55% |
| June 30, 2023 | 94.55% |
| May 31, 2023 | 94.14% |
| April 30, 2023 | 94.14% |
| March 31, 2023 | 93.86% |
| February 28, 2023 | 89.98% |
| January 31, 2023 | 89.98% |
| December 31, 2022 | 89.98% |
| November 30, 2022 | 89.98% |
| October 31, 2022 | 89.98% |
| September 30, 2022 | 89.98% |
| August 31, 2022 | 89.98% |
| July 31, 2022 | 89.98% |
| June 30, 2022 | 89.98% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Max Drawdown (5Y) Benchmarks
| Cartesian Therapeutics, Inc. | 97.12% |
| Beam Therapeutics, Inc. | 89.12% |
| Rallybio Corp. | 98.93% |
| Q32 Bio, Inc. | 99.58% |
| Arrowhead Pharmaceuticals, Inc. | 88.96% |
Max Drawdown (5Y) Related Metrics
| Alpha (5Y) | -70.04 |
| Beta (5Y) | 2.915 |
| Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 159.7% |
| Historical Sharpe Ratio (5Y) | -0.2706 |
| Historical Sortino (5Y) | -0.9537 |
| Monthly Value at Risk (VaR) 5% (5Y Lookback) | 35.97% |